Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503617 · ClinicalTrials.gov registry record · NA
RehabTouch Home Therapy for Stroke Patients
A NA study of Cerebral Stroke, sponsored by Flint Rehabilitation Devices.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT03503617: Completed NA study of Cerebral Stroke, sponsored by Flint Rehabilitation Devices.
NCT03503617 is a NA study of Cerebral Stroke that has completed, run by Flint Rehabilitation Devices. The registered enrollment target is 27 participants, below the 10,161-participant average among 6 other Cerebral Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03503617, a NA study of Cerebral Stroke, has completed, sponsored by Flint Rehabilitation Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
We will investigate the efficacy of a newly developed exercise device (RehabTouch) for people in the subacute stage after a stroke compared to a traditional tabletop exercise program. RehabTouch uses embedded sensors that can track and record the patient's direction and degree of movement as they perform exercises described on a computer.
Primary Outcome
The Fugl-Meyer Arm Motor Score is a stroke-specific, performance-based impairment index which measure 33 arm movement patterns based on a scale of 0 to 2 each, for a total possible score of 66. For each movement patter, a score of zero means the participant is unable to perform the movement pattern; a score of 2 means the participant performed the movement patterns faultlessly.
Conditions Studied
Interventions
- DEVICE RehabTouch
- OTHER Conventional tabletop exercise program
Study Locations (1)
California
- Rancho Research Institute, Inc. - Downey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT03503617 record still lists
NCT03503617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 10,161-participant average among 6 other Cerebral Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Cerebral Stroke appearing as the primary indexed condition, and to 2 interventions - of which RehabTouch is the first listed.
NCT03503617 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03503617 about?
NCT03503617 is a clinical study titled "RehabTouch Home Therapy for Stroke Patients". We will investigate the efficacy of a newly developed exercise device (RehabTouch) for people in the subacute stage after a stroke compared to a traditional tabletop exercise program. RehabTouch uses embedded sensors that can track and record the patient's direction and degree of movement as they pe...
What is the current status of trial NCT03503617?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-11-01. Estimated completion is 2021-03-31.
What conditions does trial NCT03503617 study?
This clinical trial studies the following conditions: Cerebral Stroke.
What interventions are being tested in trial NCT03503617?
The interventions under investigation include: RehabTouch (DEVICE), Conventional tabletop exercise program (OTHER).
Who is sponsoring clinical trial NCT03503617?
This trial is sponsored by Flint Rehabilitation Devices, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03503617 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Telerehabilitation Early After Stroke
RECRUITING · NA
-
Cerebral Oxygen Metabolism in Children
RECRUITING · NA
-
Telerehabilitation Early After CNS Injury
ACTIVE NOT RECRUITING · NA
-
Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke
COMPLETED · NA
-
Stroke Recovery Initiative - Registry for Stroke Research Studies
RECRUITING
-
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI